Search 

Scendea is a leading product development and regulatory consulting practice serving the pharmaceutical and biotechnology industry. We are adept at solving complex issues associated with medicinal product development and offer strategic and operational support in the fields of quality/CMC, non-clinical/toxicology, clinical/medical and regulatory. Our industry experience is demonstrable, having been involved in over 1,000 development programmes in the US and Europe over the last twenty years. As is our scientific excellence, with a team that includes ex-regulators, high-calibre academics and clinician scientists. Our technical regulatory expertise spans the entire product development spectrum from pre-clinical to marketing authorisation.

The Science Entrepreneur Club (SEC) is a London based non-profit organisation of curious minds that aims to explore and unite the life science ecosystem by educating, inspiring and connecting. We give scientists, innovators and startups, with a focus on biotech, pharma, medtech, bioengineering, biosustainability or related, a network and a unique platform to showcase their innovative technologies, find investors, meet like-minded people and accelerate their company.

Scitribe is a boutique strategic communications consultancy focused on science and technology, including profile-raising, writing and research. It combines professional corporate and scientific communications expertise with lab-based research experience.

Driven by deep understanding and enthusiasm, it applies strategic thinking and listening, combined with a roll-up-your-sleeves & "get it done" know-how, to deliver real value-add output that helps organisations achieve their business and communications objectives.

We apply big-picture thinking and specialist insights to develop strategies that effectively communicate organisations’ impact while ensuring the accurate translation of science for all target audiences and stakeholders. Scitribe provides bespoke, focused and flexible support to provide the clarity, focus, and style that effectively tells our clients’ story through the right channels, to the right audiences.

We create robust formulation development strategies tailored to the characteristics of each individual API. We complement the drug discovery process with clearly set-out costs for specific stages, totally transparent from the preclinical stage, formulation, dosage form development and optimisation.

Silence Therapeutics develops a new generation of medicines by harnessing the body’s natural mechanism of RNA interference, or RNAi, within its cells.

Our proprietary technology can selectively inhibit any gene in the genome, specifically silencing the production of disease-causing proteins. Using our enabling delivery systems, we have achieved an additional level of specificity by delivering our therapeutic RNA molecules exclusively to target cells. Silence’s proprietary RNA chemistries and delivery systems are designed to improve the stability of our molecules and enhance effective delivery to target cells, providing a powerful modular technology well suited to tackle life-threatening diseases.

We are Simbec-Orion, who for almost five decades, have been providing clinical trial management services across a wide range of therapeutic indications and phases. The clinical research organisation with a flexible, specialist approach, we strive to become a trusted partner for our clients. Our passion as a CRO is rare diseases and oncology.

Sphere Fluidics is developing picodroplets and single cell analysis systems and services for therapeutic discovery.

Specialities
Biopharmaceutical, lab-on-a-chip, cells, antibodies, microfluidics, enzymes, cancer, biologics, biotechnology, pharmaceutical, life sciences, immunology, oncology, cell therapies, and stem cells

Stratagem's "Strategically Different" approach delivers:
• An out-sourced, total intellectual property management solution.
• An investible patent strategy and maximised value of intellectual property.
• Hands-on management of the creation, maintenance, defence, commercialization, and enforcement of IP rights.
• A proven strategic approach to securing freedom to commercialise and competitive advantage.
Services For BioPartner Members:
• Free 30-minute initial consultation for IP-related matters
• IP overview training sessions for entire companies or select groups e.g. managers or inventors
• Contributions towards presentations, panel discussions, and/or Q&A sessions.